On May 28, 2020, the Board of Directors of Global Blood Therapeutics, Inc. appointed Deval L. Patrick to the Board as a Class III director. Mr. Patrick was appointed to a newly created vacancy resulting from an increase in the size of the Board from eight to nine directors.